Carmel Pharma

Carmel Pharma AB is engaged in the manufacture and distribution of products to improve the quality of life for those involved in the preparation, management, and disposal of hazardous drugs. It offers the PhaSeal system, a closed-system drug transfer device that prevents hazardous drugs from interacting with the environment. The company’s PhaSeal products are implemented in various cancer centers, oncology practices, and specialty pharmacies in the United States, as well as facilities in Europe and Asia. Carmel Pharma AB was founded in 1994 and is headquartered in Mölndal, Sweden, with an office in Columbus, Ohio.